drugset
drugset / Trial / NCT03241147

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

NCT03241147 ↗

Phase 1 Terminated 23 enrolled H. Lundbeck A/S
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the pharmacokinetics of Lu AF35700 after a single dose tablet to subjects with renal impairment (kidney insufficiency) and compare that with healthy subjects

Timeline

Start
2017-07-25
Primary completion
2019-07-17
Completion
2019-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF35700 Unknown 10 mg —

Indications

kidney failure